# Ketamine & Spravato Clinic Marketing | Fill The Lobby

> Marketing for ketamine and Spravato clinics: education-led campaigns, REMS-aware messaging, and referral pathways that hold up under scrutiny.

*Source: https://fillthelobby.com/ketamine-spravato-marketing*

## Ketamine & Spravato clinic marketing

Nobody books this on the first click. This is the most researched decision in mental health. Patients read for weeks and ask their psychiatrist before they call. Marketing that ignores that just buys expensive clicks.

You can run Google Ads for a ketamine or Spravato clinic. In US campaigns, Google lets you name a prescription drug such as Spravato in the ad and on the landing page, within the law, but only certified advertisers can target drug names as keywords, so the campaign is built on searches that don't use them. Fill The Lobby holds page and ad to one claim set, runs Spravato and IV as separate campaigns, and argues the appeal when something is pulled. Ad spend goes from your own account straight to Google.

## What actually fills infusion chairs.

### Education is the campaign

People searching ketamine therapy are frightened and curious in equal measure. The clinic that answers the questions gets the consult — the one that shouts about availability gets ignored.

### Spravato and IV are different sells

One is FDA-approved for two depression indications in adults, is REMS-bound and is given only in certified settings. The other is approved as an anesthetic and, as the [FDA restated in June 2026](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ketamine-store-wwwketaminestoreorg-725147-06232026), not for any psychiatric disorder, and it is far less understood. Running them through one funnel wastes both.

### Referrals outperform ads, so we feed both

A psychiatrist who refers once refers again. We build the pathway that makes referring easy, and use paid search to catch the people arriving on their own.

### Claims discipline

No outcome promises. No before-and-afters. No implying a treatment is approved for something it isn't. This category gets scrutinized, and we write like it.

### Consults that show up

A booked consult that no-shows costs more here than almost anywhere else. Confirmations, reminders and a real human path if they hesitate.

The clinics that win are the ones that teach first.

No patient testimonials. No outcome claims. BAA signed before any data moves.

## Spravato marketing for REMS-certified treatment centers.

Spravato can only be given in a healthcare setting certified under its REMS, a safety program the FDA requires, and every patient is monitored onsite after every dose. Those rules set your capacity, your booking page and what your ads can say, so Spravato marketing starts from them. The full checklist and the forms are in our guide to [Spravato REMS requirements](https://fillthelobby.com/blog/spravato-rems-requirements).

### Certification comes before the campaign

Under the [Spravato REMS](https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=IndvRemsDetails.page&REMS=386), an outpatient center needs a prescriber onsite during dosing and monitoring, healthcare providers and a pulse oximeter to monitor patients, an authorized representative who enrolls the setting, and written processes with trained staff. A setting that isn't certified can't receive Spravato, so until the REMS confirms you, there is nothing to book. A launch plan starts from that date, not from the day the ad account opens.

### Your chairs set the pace, not the budget

The REMS requires monitoring for at least two hours after each dose, and until sedation, dissociation and respiratory depression have resolved. The [prescribing information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d81a6a79-a74a-44b7-822c-0dfa3036eaed) starts treatment-resistant depression at twice a week for the first four weeks. So each new patient takes two long, monitored visits a week for a month, with a prescriber onsite. We pace ad spend to the monitored chairs and staff you have, not to a flat monthly number, and keep in touch with anyone who can't start yet rather than leaving them waiting in silence.

### Enrollment is clinical. The web form isn't.

Every outpatient is enrolled in the REMS on a [Patient Enrollment Form](https://www.accessdata.fda.gov/drugsatfda_docs/rems/Spravato_2026_06_24_Patient_Enrollment_Form.pdf) completed with a healthcare provider, and the prescriber's part asks for pre-existing medical and psychiatric conditions and current medications. That is intake, done with a provider. The form on your site or behind an ad takes contact details and a preferred time, and nothing about health.

### The REMS location finder lists you

The [Outpatient Healthcare Setting Enrollment Form](https://www.accessdata.fda.gov/drugsatfda_docs/rems/Spravato_2026_06_24_Outpatient_Healthcare_Setting_Enrollment_Form.pdf) says a certified setting's name, location and phone number go on a location finder for healthcare professionals and patients seeking Spravato, unless you call the REMS at 1-855-382-6022 to opt out. Treat it like any other listing: give it a number that gets answered, and a name and address that match your website and your [Google Business Profile](https://fillthelobby.com/blog/google-business-profile-for-doctors).

### Name the drug in the ad, not in the keywords

For US campaigns, Google's [restricted drug terms policy](https://support.google.com/adspolicy/answer/15595717) lets advertisers use prescription drug names in ads and landing pages without certification, within the law, but only certified advertisers can target them as keywords. Google says not to apply for a certification that doesn't match your business, and none of its examples describes an in-office treatment center. [LegitScript certification](https://fillthelobby.com/blog/legitscript-certification), which Google and Meta rely on for telehealth providers and online pharmacies, is generally not open to in-person-only clinics that don't prescribe through telemedicine or take card-not-present payments for prescription drugs. So the Google campaign runs on searches that don't use the drug name. Google also judges from your ads, site and services whether you are promoting online prescribing, and errs on the side of caution: if your site offers virtual visits that can end in a prescription, that service needs LegitScript and Google certification before it can be advertised. On Meta, the line is whether an ad promotes a prescription drug. Meta runs those ads only for LegitScript-certified advertisers and for manufacturers that pass its own review, once it has authorized them, so an in-office center without LegitScript certification can't run Meta ads that promote Spravato. Ads that only educate about a prescription drug need no written authorization.

### Spravato's claims stay on its label

The prescribing information indicates Spravato for treatment-resistant depression in adults, alone or with an oral antidepressant, and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, alongside an oral antidepressant. It also says Spravato's effectiveness in preventing suicide or reducing suicidal ideation or behavior has not been demonstrated. Ads and pages say no more than the label does, and an IV ketamine page never borrows Spravato's approval. Johnson & Johnson's [communications guide for treatment centers](https://cam-assets.janssen.com/cp-426657v1.pdf) says to include the indications, limitations of use and Important Safety Information when you communicate about Spravato, and that using its materials gives you no right or license to its logos, trademarks or images.

Sources, checked 8 October 2026: [FDA REMS@FDA listing for Spravato](https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=IndvRemsDetails.page&REMS=386) (REMS last updated 24 June 2026), the [REMS Program Overview](https://www.accessdata.fda.gov/drugsatfda_docs/rems/Spravato_2026_06_24_REMS_Program_Overview.pdf), the [Outpatient Healthcare Setting Enrollment Form](https://www.accessdata.fda.gov/drugsatfda_docs/rems/Spravato_2026_06_24_Outpatient_Healthcare_Setting_Enrollment_Form.pdf) and [Patient Enrollment Form](https://www.accessdata.fda.gov/drugsatfda_docs/rems/Spravato_2026_06_24_Patient_Enrollment_Form.pdf), the [Spravato prescribing information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d81a6a79-a74a-44b7-822c-0dfa3036eaed) on DailyMed, Google's [restricted drug terms](https://support.google.com/adspolicy/answer/15595717), [prescription drug services](https://support.google.com/adspolicy/answer/15598647) and [healthcare and medicines](https://support.google.com/adspolicy/answer/176031) policies, Meta's [drugs and pharmaceuticals ad standards](https://transparency.meta.com/policies/ad-standards/restricted-goods-services/drugs-pharmaceuticals/), LegitScript's [healthcare certification FAQ](https://www.legitscript.com/certification/healthcare-certification/faq/), and Johnson & Johnson's [Digital and Traditional Media Communications FAQ](https://cam-assets.janssen.com/cp-426657v1.pdf) for Spravato treatment centers (October 2025).

## The only agency that is also the customer.

We built and run our own clinical platforms — 200+ clinicians, patients in 20+ countries — and we spend our own money on these exact ads every day. Fill The Lobby is that engine, pointed at your practice.

## We do this in seven other specialties.

### The ad account you can lose on a Tuesday

Ketamine sits in the part of Google's policy where repeated disapprovals can escalate, after a warning, into a suspended account, and the review reads your landing page as well as your ad. A careful ad pointing at a page that talks about relief can be pulled for the page. So the claim set is identical on both, Spravato and IV run in separate campaigns rather than sharing one, so a decision against a Spravato ad is not automatically a decision against the IV ads, and the appeal is our job rather than a screenshot forwarded to you.

Most agencies meet this policy for the first time on your account, and you pay for their education in downtime. We have argued policy with Google using our own money, on our own platforms, before anyone let us near your budget. When something gets pulled, you hear what happened and what we changed, the same week it happened.

### Nobody tells them about the ride home

Spravato means at least two hours of monitoring after dosing, no driving until the next day after a restful sleep, and twice a week to start. If the first time a patient hears that is at the consult, you paid for a consult and a cancellation. Spravato marketing that leaves the logistics out books people who cannot do the schedule. So the session length, the driving rule and the early frequency go in the ad and on the booking page, before anyone takes a slot on your calendar.

That turns people away on purpose, and the booked number looks smaller for it. We would rather lose someone at the ad than in your chair, because a consult that ends at the logistics costs you the slot, the staff hour and the follow-up attached to it. If you would rather see the bigger number on the report, this is the wrong argument to have with us.

### Where the rest of it leaks

The way we structure and run [Google Ads for medical practices](https://fillthelobby.com/services/paid-ads) does not change much between specialties; what changes here is how narrow the buy has to be, and how much of your page the reviewer reads before deciding. Somebody who has been reading for three weeks is not closed by one reply and then silence, which is why [patient follow-up](https://fillthelobby.com/services/patient-follow-up) in this category runs on weeks rather than a two-day sequence written for a different specialty. None of it survives a click that lands on a brochure, so the [booking pages](https://fillthelobby.com/services/booking-pages) carry the monitoring time, the driving rule and the cash-pay answer before anyone picks a slot. The full eight, and how they hand off to each other, are laid out under [what we do](https://fillthelobby.com/services). Retention here means a treatment course completed as the prescriber planned it, not patients chased back, so the number to watch is the missed session that breaks a course, which the [patient retention calculator](https://fillthelobby.com/patient-retention-calculator) counts. All of it maps onto the [seven leaks](https://fillthelobby.com/patient-acquisition-agency#leaks) we look for in week one.

### Where people search for it

Searches like “ketamine therapy austin” that name a city add up to the most in [Texas](https://fillthelobby.com/states/texas), [California](https://fillthelobby.com/states/california) and [Colorado](https://fillthelobby.com/states/colorado). “Ketamine therapy austin” gets about 700 a month at around $6 a click, and “ketamine therapy denver” about 600 (Ahrefs, US, September 2026). Our [state pages](https://fillthelobby.com/states) list the searches and click costs for every city where they can be measured, so you can see the demand before you choose where to advertise. Those figures measure demand, not keywords you can buy: only certified advertisers can bid on prescription drug names, so the campaign itself runs on searches that don't use them.

## Ketamine and Spravato marketing, asked and answered.

**Q: Do Google Ads work for ketamine clinics?**

Someone searching a treatment by name has already done the reading, but in US campaigns only certified advertisers can bid on prescription drug names, so the campaign is built on searches that don't use them, while the ad and the page can still name the treatment. Someone typing the broad research terms is often a student, a journalist, or a patient who is nowhere near booking anything. We let the education on your site do the work the broad terms cannot, and we report on booked consults rather than clicks.

**Q: How is ketamine clinic marketing different from psychiatry marketing?**

The person searching is often not the person who would be treated. A spouse or an adult child does the reading, builds the shortlist and places the call, so the copy has to be legible to someone assessing a clinic on behalf of somebody they are worried about. That is a different ad from the one you write for a psychiatry inquiry, and it is why ketamine clinic marketing borrows less from the rest of mental health advertising than people assume.

**Q: How do I get psychiatrists to refer to my ketamine clinic?**

We build the referrer side as its own thing: a page a psychiatrist can read in under a minute, a named person with a direct line, and one obvious route for sending someone across. Referring clinicians will not chase a shared inbox or a general inquiry line, and a route that fails once tends not to get a second try. We do not build anything that pays for a referral, and we will not ask you to.

**Q: How much should a ketamine clinic spend on Google Ads a month?**

It depends on your city, whether you are bidding against a hospital program, and how many clinics want the same terms — which is what week one is for. Ad spend is separate from our fee and goes from your own account straight to Google, so you can see exactly what was spent and on what. The pilot itself is 30 days for one flat fee of $2,500.

**Q: Can I advertise Spravato by name, or is esketamine off limits?**

In a US Google Ads campaign you can name it in the ad and on the page, but you can't bid on it. Google's restricted drug terms policy lets US advertisers use prescription drug names in ads and landing pages without certification, within the law, and keeps keyword targeting of those names for certified advertisers, and none of the certification types it lists describes an in-office treatment center. Meta runs ads that promote a prescription drug only for LegitScript-certified advertisers or manufacturers it has reviewed, so an in-office center without LegitScript certification can't run Meta ads that promote Spravato; ads that only educate need no written authorization. Anything that names the drug follows the label: nothing past it, nothing that implies an approval it doesn't have, nothing that describes how a patient might feel. You and your compliance reviewer see every line before it runs.

**Q: What do Spravato marketing services include?**

For a REMS-certified center: ads built on searches that don't use the drug name, and a booking page that states the two hours of monitoring, the ride home and the twice-weekly first month before anyone picks a slot. The web form takes contact details only, because REMS enrollment is done with a provider. Ad spend is paced to the monitored chairs you have, follow-up runs for weeks rather than days, and referring psychiatrists get a page they can read in under a minute. Spravato and IV ketamine run as separate campaigns, and we report booked consults rather than clicks.

**Q: What should a Spravato booking page tell patients?**

What the REMS and the label ask of them, before they pick a slot. At least two hours onsite after every dose, and until the effects have resolved. No driving until the next day after a restful sleep, so they need a ride home. Visits twice a week for the first four weeks under the label's schedule for treatment-resistant depression. And enrollment in the Spravato REMS on a form completed with a healthcare provider. The page itself should not ask for health information: conditions and medications belong in clinical intake, not a web form.

**Q: What should I look for in a ketamine clinic marketing agency?**

Ask to see an ad in this category that has actually run and survived review, not a case study deck. Ask whose name the ad account is in, and what happens to it the day you leave. Ask which number they read every week: if the answer is impressions or leads rather than booked consults, you already know what the reports will look like.

Reviewed October 2026.

## Fill the chairs you already have.

## Related pages

- [Book a 30-minute call](https://fillthelobby.com/book)
- [Spravato REMS requirements](https://fillthelobby.com/blog/spravato-rems-requirements)
- [Google Business Profile](https://fillthelobby.com/blog/google-business-profile-for-doctors)
- [LegitScript certification](https://fillthelobby.com/blog/legitscript-certification)
- [All mental health marketing](https://fillthelobby.com/mental-health-marketing)
- [Therapy & counseling](https://fillthelobby.com/therapy-practice-marketing)
- [Psychiatry](https://fillthelobby.com/psychiatry-practice-marketing)
- [IOP & PHP](https://fillthelobby.com/iop-php-marketing)
- [Concierge & DPC](https://fillthelobby.com/concierge-dpc-marketing)
- [Functional medicine](https://fillthelobby.com/functional-medicine-marketing)
- [Weight loss & GLP-1](https://fillthelobby.com/glp1-weight-loss-marketing)
- [Gastroenterology](https://fillthelobby.com/gastroenterology-marketing)